Weber, J

Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. [electronic resource] - The British journal of dermatology 09 2020 - 559-563 p. digital

Publication Type: Case Reports; Journal Article

1365-2133

10.1111/bjd.18739 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Humans
Immunotherapy
Ipilimumab--therapeutic use
Melanoma--drug therapy
Neoadjuvant Therapy
Nivolumab--therapeutic use